# Acid Phosphatase (Prostatic), Tartrate Inhibited
> **Product code: JFH** · Class II — Moderate Risk (510(k) clearance required) · Clinical Chemistry · 21 CFR 862.1020
## Classification
- **FDA Product Code:** JFH
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 862.1020
- **Review panel:** CH
- **Medical specialty:** Clinical Chemistry
- **Submission type:** 4
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Market data
- **Cleared 510(k) submissions:** 45
- **Registered establishments:** 9
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=JFH)
---
*AI Analytics · CC0 1.0*